1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Cardiovasculares

Enfermedades Cardiovasculares

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Maggioni AP, Clark AL, Barrios V, Damy T, Drozdz J, Fonseca C, Lund LH, Kalus S, Ferber PC, Hussain RI, Koch C, Zeymer U.

    Outcomes with sacubitril/valsartan in outpatients with heart failure and reduced ejection fraction: The ARIADNE registry

    ESC heart failure . 9(6): 4209-4218. Nº de citas: 7

    [doi:10.1002/ehf2.14014]

  • Lozano-Granero C, Franco E, Matía-Francés R, Hernández-Madrid A, Sánchez-Pérez I, Zamorano JL, Moreno J.

    Characterization of high-power and very-high-power short-duration radiofrequency lesions performed with a new-generation catheter and a temperature-control ablation mode

    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY . 33(12): 2528-2537. Nº de citas: 10

    [doi:10.1111/jce.15676]

  • Anguita Sánchez M, Marín F, Masjuan J, Cosín-Sales J, Vázquez Rodríguez JM, Barrios V, Barón-Esquivias G, Lekuona I, Pérez-Cabeza AI, Freixa-Pamias R, Parra Jimenez FJ, Monzer Khanji Khatib M, Rafols Priu C, Sanmartín Fernández M.

    Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study

    Cardiology Journal . 29(6): 936-947. Nº de citas: 2

    [doi:10.5603/CJ.a2022.0091]

  • El Assar M, García-Rojo E, Sevilleja-Ortiz A, Sánchez-Ferrer A, Fernández A, García-Gómez B, Romero-Otero J, Rodríguez-Mañas L, Angulo J.

    Functional Role of STIM-1 and Orai1 in Human Microvascular Aging.

    Cells . 11(22): . Nº de citas: 9

    [doi:10.3390/cells11223675]

  • Butcher SC, Pio SM, Kong WKF, Singh GK, Ng ACT, Perry R, Sia CH, Poh KK, Almeida AG, González A, Shen M, Yeo TC, Shanks M, Popescu BA, Galian Gay L, Fijalkowski M, Liang M, Tay E, Ajmone Marsan N, Selvanayagam J, Pinto F, Zamorano JL, Pibarot P, Evangelista A, Bax JJ, Delgado V.

    Left ventricular remodelling in bicuspid aortic valve disease.

    European heart journal. Cardiovascular Imaging . 23(12): 1669-1679. Nº de citas: 20

    [doi:10.1093/ehjci/jeab284]

  • Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, Moslehi J, Moura B, Salinger SS, Stephens R, Suter TM, Szmit S, Tamargo J, Thavendiranathan P, Tocchetti CG, van der Meer P, van der Pal HJH.

    2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).

    EUROPEAN HEART JOURNAL . 43(41): 4229-4361. Nº de citas: 730

    [doi:10.1093/eurheartj/ehac244]

  • Gelves-Meza J, Lang RM, Valderrama-Achury MD, Zamorano JL, Vargas-Acevedo C, Medina HM, Salazar G.

    Tricuspid Regurgitation Related to Cardiac Implantable Electronic Devices: An Integrative Review

    JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY . 35(11): 1107-1122. Nº de citas: 47

    [doi:10.1016/j.echo.2022.08.004]

  • Marin F, Fernández MS, Lekuona I, Arribas F, Barón-Esquivias G, Barrios V, Cosin-Sales J, Freixa-Pamias R, Masjuan J, Pérez-Cabeza AI, Schilling VR, Vázquez Rodríguez JM, Priu CR, Sánchez MA.

    Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries.

    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH . 11(16): 1173-1184.

    [doi:10.2217/cer-2022-0111]

  • Lima da Silva G, Cortez-Dias N, Nunes Ferreira A, Nakar E, Francisco R, Pereira M, Moreno J, Martins RP, Pinto FJ, de Sousa J.

    Impact of different activation wavefronts on ischemic myocardial scar electrophysiological properties during high-density ventricular tachycardia mapping and ablation.

    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY . 34(2): 389-399. Nº de citas: 5

    [doi:10.1111/jce.15740]

  • González-Juanatey C, Anguita-Sánchez M, Barrios V, Núñez-Gil I, Gómez-Doblas JJ, García-Moll X, Lafuente-Gormaz C, Rollán-Gómez MJ, Peral-Disdier V, Martínez-Dolz L, Rodríguez-Santamarta M, Viñolas-Prat X, Soriano-Colomé T, Muñoz-Aguilera R, Plaza I, Curcio-Ruigómez A, Orts-Soler E, Segovia J, Fanjul V, Cequier Á, Savana Research Group.

    Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing

    Journal Of Clinical Medicine . 11(20): . Nº de citas: 10

    [doi:10.3390/jcm11206004]

  • Pazdernik M, Iung B, Mutlu B, Alla F, Riezebos R, Kong W, Nunes MCP, Pierard L, Srdanovic I, Yamada H, De Martino A, Miglioranza MH, Magne J, Piper C, Laroche C, Maggioni AP, Lancellotti P, Habib G, Selton-Suty C.

    Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry.

    Infection . 50(5): 1191-1202. Nº de citas: 22

    [doi:10.1007/s15010-022-01792-0]

  • Evangelista Masip A, López-Sainz Á, Barros Membrilla AJ, Calvo Iglesias F, López Ayerbe J, Azqueta Molluna M, Mosquera Rodríguez VX, Arregui Montoya F, Tarrío Fernández R, Revilla Orodea A, Sánchez Sánchez V, Cantero Pérez EM, Ferrera C, Toral Sepúlveda D, Nistal F, Fernández Golfín C, Sao A, Rodríguez-Palomares J.

    Spanish Registry of Acute Aortic Syndrome (RESA). Changes in therapeutic management and lower mortality in acute aortic syndrome

    REVISTA ESPANOLA DE CARDIOLOGIA . 75(10): 816-824. Nº de citas: 8

    [doi:10.1016/j.rec.2022.01.017]

  • Espindola R, Vella V, Benito N, Mur I, Tedeschi S, Rossi N, Hendriks JGE, Sorlí L, Murillo O, Scarborough M, Scarborough C, Kluytmans J, Ferrari MC, Pletz MW, Mcnamara I, Escudero-Sanchez R, Arvieux C, Batailler C, Dauchy FA, Liu WY, Lora-Tamayo J, Praena J, Ustianowski A, Cinconze E, Pellegrini M, Bagnoli F, Rodríguez-Baño J, Del Toro MD.

    Preoperative and perioperative risk factors, and risk score development for prosthetic joint infection due to Staphylococcus aureus: a multinational matched case-control study

    CLINICAL MICROBIOLOGY AND INFECTION . 28(10): 1359-1366. Nº de citas: 14

    [doi:10.1016/j.cmi.2022.05.010]

  • Rincón LM, Rodríguez-Serrano M, Conde E, Lanza VF, Sanmartín M, González-Portilla P, Paz-García M, del Rey JM, Menacho M, García Bermejo ML, Zamorano JL.

    Serum microRNAs are key predictors of long-term heart failure and cardiovascular death after myocardial infarction.

    ESC heart failure . 9(5): 3367-3379. Nº de citas: 26

    [doi:10.1002/ehf2.13919]

  • Turégano-Yedro M, Ruiz-García A, Castillo-Moraga MJ, Jiménez-Baena E, Barrios V, Serrano-Cumplido A, Pallarés-Carratalá V.

    [The natriuretic peptides in the diagnosis of heart failure in primary care setting].

    MEDICINA DE FAMILIA-SEMERGEN . 48(7): 101812-101812.

    [doi:10.1016/j.semerg.2022.101812]

  • Sans-Roselló J, Fernández-Peregrina E, Duran-Cambra A, Carreras-Mora J, Sionis A, Álvarez-García J, García-García HM.

    Prognostic Value of Microvascular Resistance at Rest in Patients With Takotsubo Syndrome

    JACC-CARDIOVASCULAR IMAGING . 15(10): 1784-1795. Nº de citas: 33

    [doi:10.1016/j.jcmg.2022.03.030]

  • Tesoro L, Hernández I, Ramírez-Carracedo R, Díez-Mata J, Alcharani N, Jiménez-Guirado B, Ovejero-Paredes K, Filice M, Zamorano JL, Saura M, Zaragoza C, Botana L.

    NIL10: A New IL10-Receptor Binding Nanoparticle That Induces Cardiac Protection in Mice and Pigs Subjected to Acute Myocardial Infarction through STAT3/NF-?B Activation

    Pharmaceutics . 14(10): . Nº de citas: 12

    [doi:10.3390/pharmaceutics14102044]

  • Balderas C, Angulo J, Sevilleja-Ortiz A, Peiró C, Vallejo S, Dongil P, Ancos B, Sánchez-Moreno C.

    Onion and Apple Functional Ingredients Intake Improves Antioxidant and Inflammatory Status and Vascular Injury in Obese Zucker Rats

    Antioxidants . 11(10): . Nº de citas: 5

    [doi:10.3390/antiox11101953]